Meritage Group’s Merck MRK Stock Holding History

Meritage Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,292	Closed	-$284K	–	47
2024 Q2	$284K	Buy	2,292 +159	+7%	+$20.5K	0.01%	40
2024 Q1	$281K	Sell	2,133 -740	-26%	-$91.2K	0.01%	38
2023 Q4	$313K	Buy	+2,873	New	+$298K	0.01%	27

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meritage Group's MRK Position: Q3 2024 in Review

Meritage Group sold out of Merck (MRK) in Q3 2024, closing a stake of 2,292 shares — an estimated $284K sold.

Meritage Group first reported a position in MRK in Q4 2023 and held it in 3 quarters. The position peaked at $313K in Q4 2023. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Meritage Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Meritage Group sold 2,292 Merck shares in Q3 2024, an estimated $284K.
Meritage Group first reported a position in Merck in Q4 2023 and held it in 3 quarters.
Meritage Group's Merck position peaked at $313K in Q4 2023.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Meritage Group's 13F filing for Q3 2024, filed 15 Nov 2024.